about
Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccineIE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.Successes and challenges in varicella vaccineParadigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancerAn overview of predictors for persistent neuropathic pain.Functional decline and herpes zoster in older people: an interplay of multiple factors.Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?Cytotoxicity of glioblastoma cells mediated ex vivo by varicella-zoster virus-specific T cells.Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.Evaluation of a TaqMan Array Card for Detection of Central Nervous System Infections.Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms.Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.Satellite lesions accompanying herpes zoster: a new prognostic sign for high-risk zoster.Varicella zoster virus quantitation in blood from symptomatic and asymptomatic individuals.Virus serology in patients with suspected myocarditis: utility or futility?
P2860
Q33386017-7EA509F6-F777-4041-8748-B2D59E5454ABQ33585318-302EE0AA-9AB7-4479-8FE3-37ADC809EE1DQ33723698-DA918C59-C34D-4AA0-B1FA-0D698E9EE7F1Q34416710-C8D1F1E8-2D58-4B72-9830-5805204936F2Q35258843-0B820647-48A2-4B4A-A173-2D7A7E3A19B1Q38101983-247BB81B-35B3-4ECC-8180-5A51FA93645BQ38600346-256B8A79-9DE2-40AC-A8C8-1A7814AFBCEFQ38667215-0DBA7C9F-EB4C-433C-B19F-E36FA400C5A3Q39500326-9129A5E8-7BC4-4FC8-B3AD-FA5F795B5FEDQ39998958-9CF9F43C-5E5A-4B42-960E-706D9829A4FCQ40061283-F1FDF929-7376-46D1-A846-E4849E5DE15DQ40106448-0FC02A06-8C48-4E32-A267-D413291C3EA2Q40162587-77C7ED3F-7A53-438E-A36B-F87D53779F4FQ41628201-D21B845E-512C-4F50-9BB5-D54105DCFB06Q42259029-55A8CDC3-E991-4013-8189-00377CEA6AD1Q45369959-32E60D10-7377-44B9-8266-65ADA8FE5D52
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Effect of viral load on the outcome of herpes zoster
@ast
Effect of viral load on the outcome of herpes zoster
@en
type
label
Effect of viral load on the outcome of herpes zoster
@ast
Effect of viral load on the outcome of herpes zoster
@en
prefLabel
Effect of viral load on the outcome of herpes zoster
@ast
Effect of viral load on the outcome of herpes zoster
@en
P2093
P2860
P356
P1476
Effect of viral load on the outcome of herpes zoster
@en
P2093
M L Quinlivan
M Leedham-Green
R W Johnson
S McElwaine
P2860
P304
P356
10.1128/JCM.00874-07
P407
P577
2007-09-12T00:00:00Z